Surgical treatment of mucoepidermoid carcinoma of the lung: 20 years’ experience

Abstract

Complete surgical resection is important for long-term survival in patients with pulmonary mucoepidermoid carcinoma. The techniques of bronchoplasty and extended resection may contribute to better surgical management of this disease. Endobronchial interventions may be considered for the management of obstructive pneumonia prior to surgery.

Clinicopathological characteristics and molecular analysis of primary pulmonary mucoepidermoid carcinoma: Case report and literature review

“…Several published reviews confirm that complete surgical resection remains the best treatment choice for PMEC and can result in better long‐term survival compared to non‐surgical treatment . Advanced disease at the time of initial diagnosis may make complete resection difficult, especially in cases of high‐grade PMEC.…”

“…Advanced disease at the time of initial diagnosis may make complete resection difficult, especially in cases of high‐grade PMEC. Because PMEC is a type of non‐small cell lung cancer, adjuvant therapy should be administered when complete resection is not possible, although the utility of chemotherapy and radiotherapy in these cases remains controversial …”

“…Several published reviews confirm that complete surgical resection remains the best treatment choice for PMEC and can result in better long-term survival compared to nonsurgical treatment. [4][5][6]12 Advanced disease at the time of initial diagnosis may make complete resection difficult, especially in cases of high-grade PMEC. Because PMEC is a type of non-small cell lung cancer, adjuvant therapy should be administered when complete resection is not possible, although the utility of chemotherapy and radiotherapy in these cases remains controversial.…”

“…first described pulmonary mucoepidermoid carcinoma (PMEC) in 1952 . It is an extremely rare malignant neoplasm of the lung that accounts for approximately 0.1–0.2% of all lung malignancies . PMEC is a salivary gland‐type tumor of the lung, deriving from the minor salivary glands of the tracheobronchial tree and has been reported to occur over an age range of 3–78 years .…”

“…[1][2][3][4] It is an extremely rare malignant neoplasm of the lung that accounts for approximately 0.1-0.2% of all lung malignancies. [3][4][5][6][7] PMEC is a salivary gland-type tumor of the lung, 5,8 deriving from the minor salivary glands of the tracheobronchial tree 9 and has been reported to occur over an age range of 3-78 years. 3,10,11 Compared to other salivary gland-type tumors of the lung, there is no gender predilection in PMEC.…”